Tairen Capital Ltd Makes New $39.40 Million Investment in Celestica, Inc. $CLS

Tairen Capital Ltd purchased a new position in Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 108,000 shares of the technology company’s stock, valued at approximately $39,398,000. Celestica makes up about 3.5% of Tairen Capital Ltd’s investment portfolio, making the stock its 10th biggest holding. Tairen Capital Ltd owned about 0.09% of Celestica as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Celestica during the fourth quarter valued at $28,000. Ascentis Independent Advisors bought a new stake in Celestica in the first quarter worth $29,000. Swiss RE Ltd. purchased a new stake in shares of Celestica in the fourth quarter worth $29,000. Cullen Frost Bankers Inc. purchased a new stake in shares of Celestica in the fourth quarter worth $30,000. Finally, Sittner & Nelson LLC bought a new position in shares of Celestica during the fourth quarter valued at $31,000. Hedge funds and other institutional investors own 67.38% of the company’s stock.

Insider Activity at Celestica

In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the sale, the chief financial officer directly owned 82,444 shares of the company’s stock, valued at approximately $32,948,744.60. This represents a 17.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Robert Mionis sold 98,453 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total transaction of $36,328,172.47. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 356,553 shares of company stock worth $135,238,444 in the last quarter. Company insiders own 1.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CLS. TD Securities raised shares of Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective on the stock in a research report on Wednesday, April 29th. UBS Group raised shares of Celestica from a “neutral” rating to a “buy” rating and set a $430.00 target price for the company in a report on Monday. TD Cowen upgraded shares of Celestica from a “hold” rating to a “buy” rating and upped their target price for the stock from $350.00 to $430.00 in a research note on Wednesday, April 29th. Susquehanna increased their price target on shares of Celestica from $460.00 to $510.00 and gave the company a “positive” rating in a report on Wednesday, April 29th. Finally, Barclays reduced their price target on shares of Celestica from $430.00 to $406.00 and set an “overweight” rating for the company in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $439.81.

Read Our Latest Analysis on CLS

Celestica Stock Performance

Shares of CLS opened at $296.03 on Monday. The firm has a market capitalization of $34.04 billion, a P/E ratio of 30.77 and a beta of 2.06. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. Celestica, Inc. has a one year low of $179.01 and a one year high of $474.02. The business has a fifty day moving average of $341.15 and a 200 day moving average of $335.51.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last posted its earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, beating analysts’ consensus estimates of $2.29 by $0.25. The company had revenue of $4.68 billion for the quarter, compared to the consensus estimate of $4.30 billion. Celestica had a return on equity of 39.96% and a net margin of 7.16%.Celestica’s revenue was up 62.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.39 earnings per share. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, sell-side analysts anticipate that Celestica, Inc. will post 10.15 EPS for the current year.

Celestica Company Profile

(Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Read More

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS).

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.